Kadcyla (trastuzumab emtansine)

pCPA File Number: 21170
Negotiation Status:
Concluded with an LOI
Indication(s):
Early Breast Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0182-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: